<p>(<b>A</b>) IL-1β plasma concentrations. (<b>B</b>) IL-6 plasma concentrations. (<b>C</b>) IL-8 plasma concentrations. (<b>D</b>). TNF-α plasma concentrations. Imatinib (N = 4) compared to PBS (N = 4). Data presented as the mean ± SD. ***P<0.001.</p
This study aimed to determine whether published pharmacokinetic (PK) models can adequately predict t...
<p>(A) serum IL-6, interleukin-6; (B) serum TNF-α, tumor necrosis factor-α. Data are presented as me...
Purpose: While imatinib has revolutionized the treatment of chronic myeloid leukaemia (CML) and gast...
<p>(A–D) Genome wide expression array analysis performed on inguinal lymph node cells harvested from...
<p>Effects of 30 minute delayed imatinib treatment on MPO immunoreactive neutrophils within the inju...
BackgroundThis study evaluates the correlation between imatinib trough plasma concentrations (C(min)...
Background: Imatinib reduced 90-day mortality in hospitalised coronavirus disease 2019 (COVID-19) pa...
<p>Influence of (A) extracellular pH and (B/E) pro-inflammatory cytokines (each at 10 ng/ml) on spec...
<p>INS-1 832/13 cells were left untreated (control), treated with cytokines (50 U/ml IL-1β+1000 U/ml...
Background: Imatinib has revolutionized the treatment of chronic myeloid leukemia (CML) and gastroin...
Recently, the overall survival (OS) and progression-free survival (PFS) of patients with advanced ca...
Background Blood-based biomarkers of anti-solid tumor immune checkpoint blockade (ICB) response are ...
Several population pharmacokinetic (PPK) analyses of the anticancer drug imatinib have been performe...
<p>Values are means ± SD.</p>*<p><i>P</i><0.05 vs. ARDS;</p>§<p><i>P</i><0.05 vs. Con;</p>†<p><i>P</...
<p>TNFα, MCP-1, and IL-6 concentration was assessed in serum after 3h of poly I:C or PBS treatment, ...
This study aimed to determine whether published pharmacokinetic (PK) models can adequately predict t...
<p>(A) serum IL-6, interleukin-6; (B) serum TNF-α, tumor necrosis factor-α. Data are presented as me...
Purpose: While imatinib has revolutionized the treatment of chronic myeloid leukaemia (CML) and gast...
<p>(A–D) Genome wide expression array analysis performed on inguinal lymph node cells harvested from...
<p>Effects of 30 minute delayed imatinib treatment on MPO immunoreactive neutrophils within the inju...
BackgroundThis study evaluates the correlation between imatinib trough plasma concentrations (C(min)...
Background: Imatinib reduced 90-day mortality in hospitalised coronavirus disease 2019 (COVID-19) pa...
<p>Influence of (A) extracellular pH and (B/E) pro-inflammatory cytokines (each at 10 ng/ml) on spec...
<p>INS-1 832/13 cells were left untreated (control), treated with cytokines (50 U/ml IL-1β+1000 U/ml...
Background: Imatinib has revolutionized the treatment of chronic myeloid leukemia (CML) and gastroin...
Recently, the overall survival (OS) and progression-free survival (PFS) of patients with advanced ca...
Background Blood-based biomarkers of anti-solid tumor immune checkpoint blockade (ICB) response are ...
Several population pharmacokinetic (PPK) analyses of the anticancer drug imatinib have been performe...
<p>Values are means ± SD.</p>*<p><i>P</i><0.05 vs. ARDS;</p>§<p><i>P</i><0.05 vs. Con;</p>†<p><i>P</...
<p>TNFα, MCP-1, and IL-6 concentration was assessed in serum after 3h of poly I:C or PBS treatment, ...
This study aimed to determine whether published pharmacokinetic (PK) models can adequately predict t...
<p>(A) serum IL-6, interleukin-6; (B) serum TNF-α, tumor necrosis factor-α. Data are presented as me...
Purpose: While imatinib has revolutionized the treatment of chronic myeloid leukaemia (CML) and gast...